Related references
Note: Only part of the references are listed.Overcoming Pharmaceutical Bottlenecks for Nucleic Acid Drug Development
Mei Lu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2023)
Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia
Bo Hu et al.
SCIENCE ADVANCES (2022)
Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
Jiulong Zhang et al.
ACTA PHARMACEUTICA SINICA B (2022)
A Photoactivatable Silencing Extracellular Vesicle (PASEV) that Sensitizes Cancer Immunotherapy
Mei Lu et al.
ADVANCED MATERIALS (2022)
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Yanyan Xu et al.
ACTA PHARMACEUTICA SINICA B (2022)
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
Tae Kon Kim et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Combination strategies to maximize the benefits of cancer immunotherapy
Shaoming Zhu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Nucleic acid delivery with extracellular vesicles
Michaela Schulz-Siegmund et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Bioinspired exosome-like therapeutics and delivery nanoplatforms
Mei Lu et al.
BIOMATERIALS (2020)
Viral Protein-Pseudotyped and siRNA-Electroporated Extracellular Vesicles for Cancer Immunotherapy
Houli Liu et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
PAK4 inhibition improves PD-1 blockade immunotherapy
Gabriel Abril-Rodriguez et al.
NATURE CANCER (2020)
Combining Nanomedicine and Immunotherapy
Yang Shi et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery
Mei Lu et al.
ACTA BIOMATERIALIA (2019)
Liposome-chaperoned cell-free synthesis for the design of proteoliposomes: Implications for therapeutic delivery
Mei Lu et al.
ACTA BIOMATERIALIA (2018)
Functionalized extracellular vesicles as advanced therapeutic nanodelivery systems
Mei Lu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
On the use of liposome controls in studies investigating the clinical potential of extracellular vesicle-based drug delivery systems - A commentary
Kasper Bendix Johnsen et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Self-Assembly of Extracellular Vesicle-like Metal-Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins
Gong Cheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Exosome-based small RNA delivery: Progress and prospects
Mei Lu et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA
Mei Lu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities
Mei Lu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
A Breakthrough: Macrophage-Directed Cancer Immunotherapy
Charles D. Mills et al.
CANCER RESEARCH (2016)
Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth
Omran Abu Aboud et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
PAK signalling during the development and progression of cancer
Maria Radu et al.
NATURE REVIEWS CANCER (2014)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)